| Glomerular actions of endothelin in vivo. V Kon, T Yoshioka, A Fogo, I Ichikawa The Journal of clinical investigation 83 (5), 1762-1767, 1989 | 468 | 1989 |
| Role of endothelin in cyclosporine-induced glomerular dysfunction V Kon, M Sugiura, T Inagami, BR Harvie, I Ichikawa, RL Hoover Kidney international 37 (6), 1487-1491, 1990 | 454 | 1990 |
| Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay M Sugiura, T Inagami, V Kon Biochemical and biophysical research communications 161 (3), 1220-1227, 1989 | 341 | 1989 |
| Biological actions and pathophysiological significance of endothelin in the kidney V Kon Kidney Int 40, 1-12, 1991 | 292 | 1991 |
| Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy TE Hunley, BA Julian, JA Phillips III, ML Summar, H Yoshida, RG Horn, ... Kidney international 49 (2), 571-577, 1996 | 289 | 1996 |
| Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus H Yoshida, S Kuriyama, Y Atsumi, H Tomonari, T Mitarai, A Hamaguchi, ... Kidney international 50 (2), 657-664, 1996 | 266 | 1996 |
| Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition V Kon, A Fogo, I Ichikawa, SE Hellings, T Bills Kidney international 44 (3), 545-550, 1993 | 253 | 1993 |
| Conditional knockout of macrophage PPARγIncreases atherosclerosis in C57BL/6 and low-density lipoprotein receptor–deficient mice VR Babaev, PG Yancey, SV Ryzhov, V Kon, MD Breyer, MA Magnuson, ... Arteriosclerosis, thrombosis, and vascular biology 25 (8), 1647-1653, 2005 | 226 | 2005 |
| Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity A Fogo, SE Hellings, T Inagami, V Kon Kidney international 42 (3), 770-774, 1992 | 215 | 1992 |
| Dysfunctional high-density lipoprotein in patients on chronic hemodialysis S Yamamoto, PG Yancey, TA Ikizler, WG Jerome, R Kaseda, B Cox, ... Journal of the American College of Cardiology 60 (23), 2372-2379, 2012 | 213 | 2012 |
| Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Rapid Communication J Ma, H Nishimura, A Fogo, V Kon, T Inagami, I Ichikawa Kidney international 53 (4), 937-944, 1998 | 211 | 1998 |
| Role for angiotensin II in an overt functional proteinuria T Yoshioka, T Mitarai, V Kon, WM Deen, HG Rennke, I Ichikawa Kidney international 30 (4), 538-545, 1986 | 186 | 1986 |
| Scope and mechanisms of obesity-related renal disease TE Hunley, LJ Ma, V Kon Current opinion in nephrology and hypertension 19 (3), 227-234, 2010 | 181 | 2010 |
| Absence of angiotensin II type 1 receptor in bone marrow–derived cells is detrimental in the evolution of renal fibrosis M Nishida, H Fujinaka, T Matsusaka, J Price, V Kon, AB Fogo, ... The Journal of clinical investigation 110 (12), 1859-1868, 2002 | 152 | 2002 |
| Podocyte injury damages other podocytes T Matsusaka, E Sandgren, A Shintani, V Kon, I Pastan, AB Fogo, ... Journal of the American Society of Nephrology 22 (7), 1275-1285, 2011 | 139 | 2011 |
| Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms R Tanaka, V Kon, T Yoshioka, I Ichikawa, A Fogo Kidney international 45 (2), 537-543, 1994 | 138 | 1994 |
| Mechanisms for increased cardiovascular disease in chronic kidney dysfunction S Yamamoto, V Kon Current opinion in nephrology and hypertension 18 (3), 181-188, 2009 | 129 | 2009 |
| Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis S Yamamoto, PG Yancey, Y Zuo, LJ Ma, R Kaseda, AB Fogo, I Ichikawa, ... Arteriosclerosis, thrombosis, and vascular biology 31 (12), 2856-2864, 2011 | 127 | 2011 |
| Proteomic patterns and prediction of glomerulosclerosis and its mechanisms BJ Xu, Y Shyr, X Liang, L Ma, EM Donnert, JD Roberts, X Zhang, V Kon, ... Journal of the American Society of Nephrology 16 (10), 2967-2975, 2005 | 125 | 2005 |
| Inhibition of 11β–hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans MZ Zhang, J Xu, B Yao, H Yin, Q Cai, MJ Shrubsole, X Chen, V Kon, ... The Journal of clinical investigation 119 (4), 876-885, 2009 | 121 | 2009 |
